141 related articles for article (PubMed ID: 15624557)
1. Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution.
Ritter MR; Moreno SK; Dorrell MI; Rubens J; Ney J; Friedlander DF; Bergman J; Cunningham BB; Eichenfield L; Reinisch J; Cohen S; Veccione T; Holmes R; Friedlander SF; Friedlander M
Lymphat Res Biol; 2003; 1(4):291-9. PubMed ID: 15624557
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis.
Ritter MR; Dorrell MI; Edmonds J; Friedlander SF; Friedlander M
Proc Natl Acad Sci U S A; 2002 May; 99(11):7455-60. PubMed ID: 12032304
[TBL] [Abstract][Full Text] [Related]
3. Immune response: A possible role in the pathophysiology of hemangioma.
Sun ZJ; Zhao YF; Zhang WF
Med Hypotheses; 2007; 68(2):353-5. PubMed ID: 16997493
[TBL] [Abstract][Full Text] [Related]
4. Myeloid cells in infantile hemangioma.
Ritter MR; Reinisch J; Friedlander SF; Friedlander M
Am J Pathol; 2006 Feb; 168(2):621-8. PubMed ID: 16436675
[TBL] [Abstract][Full Text] [Related]
5. Biomolecular markers and involution of hemangiomas.
Frischer JS; Huang J; Serur A; Kadenhe A; Yamashiro DJ; Kandel JJ
J Pediatr Surg; 2004 Mar; 39(3):400-4. PubMed ID: 15017560
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells and adipogenesis in hemangioma involution.
Yu Y; Fuhr J; Boye E; Gyorffy S; Soker S; Atala A; Mulliken JB; Bischoff J
Stem Cells; 2006 Jun; 24(6):1605-12. PubMed ID: 16456130
[TBL] [Abstract][Full Text] [Related]
7. Potential roles of allograft inflammatory factor-1 in the pathogenesis of hemangiomas.
Jia J; Zhao YF; Zhao JH
Med Hypotheses; 2007; 68(2):288-90. PubMed ID: 17010532
[TBL] [Abstract][Full Text] [Related]
8. Growth characteristics of infantile hemangiomas: implications for management.
Chang LC; Haggstrom AN; Drolet BA; Baselga E; Chamlin SL; Garzon MC; Horii KA; Lucky AW; Mancini AJ; Metry DW; Nopper AJ; Frieden IJ;
Pediatrics; 2008 Aug; 122(2):360-7. PubMed ID: 18676554
[TBL] [Abstract][Full Text] [Related]
9. Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence.
Nguyen VA; Kutzner H; Fürhapter C; Tzankov A; Sepp N
Mod Pathol; 2006 Feb; 19(2):291-8. PubMed ID: 16424896
[TBL] [Abstract][Full Text] [Related]
10. [A new mechanism of tumor resistance to the immune system, based on tryptophan breakdown by indoleamine 2,3-dioxygenase].
Van den Eynde B
Bull Mem Acad R Med Belg; 2003; 158(7-9):356-63; discussion 364-5. PubMed ID: 15132006
[TBL] [Abstract][Full Text] [Related]
11. Congenital hemangiomas.
Boull C; Maguiness SM
Semin Cutan Med Surg; 2016 Sep; 35(3):124-7. PubMed ID: 27607320
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
[TBL] [Abstract][Full Text] [Related]
13. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells.
Yu Y; Varughese J; Brown LF; Mulliken JB; Bischoff J
Am J Pathol; 2001 Dec; 159(6):2271-80. PubMed ID: 11733376
[TBL] [Abstract][Full Text] [Related]
14. A postulated role for transcriptional regulator LMO2 in the proliferation and involution of hemangioma.
Sun ZJ; Zhang L; Zhao YF
Med Hypotheses; 2006; 67(5):1230-2. PubMed ID: 16793212
[TBL] [Abstract][Full Text] [Related]
15. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling.
Calicchio ML; Collins T; Kozakewich HP
Am J Pathol; 2009 May; 174(5):1638-49. PubMed ID: 19349369
[TBL] [Abstract][Full Text] [Related]
16. Increased apoptosis coincides with onset of involution in infantile hemangioma.
Razon MJ; Kräling BM; Mulliken JB; Bischoff J
Microcirculation; 1998; 5(2-3):189-95. PubMed ID: 9789259
[TBL] [Abstract][Full Text] [Related]
17. Congenital nonprogressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma.
North PE; Waner M; James CA; Mizeracki A; Frieden IJ; Mihm MC
Arch Dermatol; 2001 Dec; 137(12):1607-20. PubMed ID: 11735711
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.
Xiao BG; Liu X; Link H
Steroids; 2004 Sep; 69(10):653-9. PubMed ID: 15465110
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance.
Hönig A; Rieger L; Kapp M; Sütterlin M; Dietl J; Kämmerer U
J Reprod Immunol; 2004 Apr; 61(2):79-86. PubMed ID: 15063631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
